| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152883 isolation of ligament cells, then culturing, recovering and implanting the cells into patients |
| 07/14/2005 | US20050152877 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS receptors |
| 07/14/2005 | US20050152876 administering PTX3 to increase the amount or activity of Pentraxin 3 in the cumulous oophorus and/or the extracellular matrix of the cumulous oophorus |
| 07/14/2005 | US20050152871 treating the subject in need with one or more chemokines and/or a DNA damaging agent inducing said chemokine(s); |
| 07/14/2005 | US20050152870 Pharmaceutical composition which improves in vivo gene transfer |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | DE10358407A1 Antiapoptorisch wirksame Aptamere (zur Therapie von Herz-Kreislauf Erkrankungen) Antiapoptorisch effective aptamers (for the treatment of cardiovascular diseases) |
| 07/14/2005 | DE10131145B4 Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen Composition for cell-specific transfer of drugs |
| 07/14/2005 | CA2592504A1 Classification of cancer |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551553A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 07/14/2005 | CA2551100A1 Compositions and methods for combined therapy of disease |
| 07/14/2005 | CA2550326A1 Use of human cord blood-derived pluripotent cells for the treatment of disease |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553176A1 Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552852A1 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 07/13/2005 | EP1552018A2 Methods and compositions relating to gene silencing |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551981A1 Expressional enhancers from viruses |
| 07/13/2005 | EP1551980A2 Stabilized naked dna compositions |
| 07/13/2005 | EP1551974A1 Vector system |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551859A2 Aav itr-mediated modulation |
| 07/13/2005 | EP1551440A2 Uses of human zven proteins and polynucleotides |
| 07/13/2005 | EP1551227A2 Preventing secondary lymphedema with vegf-d dna |
| 07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639330A Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides |
| 07/13/2005 | CN1639325A A method for producing recombinant viruses using site-specific recombination |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639321A Bacterial spores |
| 07/13/2005 | CN1639228A Carbohydrate-modified polymers, compositions and uses related thereto |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638795A MVA expressing modified HIV envelope, GAG, and pol genes |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1637142A Hepatitis B virus gene siRNA sequence and its use |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2005 | US6916918 Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 07/12/2005 | US6916843 Prevention cell damage due oxygen toxicity by administering epoxyeicosatrienoic acids and/or metabolites, from cytochrome-P450 monooxygenase enzyme ststem |
| 07/12/2005 | US6916793 Treating tumor cells with a selenium prodrug lyase and a selenium-containing prodrug such as selenocysteine, selenohomocysteine, selenomethionine or selenoethionine. |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916786 Especially Keratinocyte Growth Factor 12; accelerating wound healing and treating gastrointestinal and respiratory disorders. |
| 07/12/2005 | US6916654 Universal donor cells |
| 07/12/2005 | US6916653 Ribozymal nucleic acid |
| 07/12/2005 | US6916648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/12/2005 | US6916635 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 07/12/2005 | US6916624 Antibody for use in the diagnosis and treatment of cancer |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | US6916490 Coacervate microsphere of polycationic and polyanionic molecules crosslinked by a crosslinked agent with a metal cation, a nucleic acid and a delivery agent |
| 07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
| 07/12/2005 | US6916470 Methods for use of mpl ligands with primitive human stem cells |
| 07/12/2005 | CA2172974C Poly-amino acidic oligonucleotide-carrier |
| 07/07/2005 | WO2005061721A1 Novel high-titre retroviral vector and transduction methods |
| 07/07/2005 | WO2005061710A1 Oligomeric compounds for the modulation of bcl-2 |
| 07/07/2005 | WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | WO2005061002A2 Composition and methods for modulating cns activity |
| 07/07/2005 | WO2005060934A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/07/2005 | WO2005060746A1 Delivery of viral vectors to extravascular parenchymal cells |
| 07/07/2005 | WO2005060721A2 Manipulation of rna interference through modulation of armitage activity |
| 07/07/2005 | WO2005060542A2 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/07/2005 | WO2005060479A2 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 07/07/2005 | WO2005030253A3 Photocleavable dna transfer agent |
| 07/07/2005 | WO2005007109A3 Methods and compositions for cancer therapy using a novel adenovirus |
| 07/07/2005 | WO2004111248A3 Improved aav vector for gene therapy |
| 07/07/2005 | WO2004108938B1 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 07/07/2005 | WO2004092340A3 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 07/07/2005 | WO2004091500A3 Delivery of immune response modifier compounds |
| 07/07/2005 | WO2004080425A3 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/07/2005 | WO2004050007A3 Mammalian bt-42 proteins involved in the regulation of energy homeostasis |
| 07/07/2005 | WO2004022579A3 Cellular delivery of natriuretic peptides |
| 07/07/2005 | WO2003089583A3 Tissue specific genes and gene clusters |
| 07/07/2005 | WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/07/2005 | US20050149998 Transgenic mouse embryonic stem cells for use as models in expression of heterologous genes |
| 07/07/2005 | US20050149995 Using transgenic animal cells as bioreactor for propagation of connective tissue protein for use in treatment of collagen diseases |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148535 Inducing apoptosis in cancer cells; expression vectors, cells; kits |
| 07/07/2005 | US20050148534 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 07/07/2005 | US20050148533 Modulation of RANKL expression |
| 07/07/2005 | US20050148532 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 07/07/2005 | US20050148531 Antisense agents; blocking agents (biotin); high throughput screening |
| 07/07/2005 | US20050148530 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery |
| 07/07/2005 | US20050148529 Nucleic acid immunization |
| 07/07/2005 | US20050148528 Via antisense oligonucleotides that inhibit the expression of raf-1 gene, formulated in liposomes with enhanced penetration into cells; free of chemotherapy/radiation treatments |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148514 Method and composition for treatment of angiogenesis |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148500 Proteinaceous factor isolatable from X61 cells has the ability to increase the dopamine content in neurons |
| 07/07/2005 | US20050148496 Methotrexate resistant, a TNF- alpha antagonist, an interleukin-1 receptor antagonist and a steroid; drug screening; |